Literature DB >> 17401157

Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke.

Ole F Olesen1, Bente Bennike, Henrik Dam, Erling Mellerup.   

Abstract

Serotonin (5-HT) has been implicated in a number of cardiovascular disorders due to its ability to induce vascular contraction and platelet aggregation through activation of the 5-HT2 receptor family. In this study, we investigated the association of stroke in a Scandinavian population with two common polymorphisms in the 5-HT2A receptor gene. The two polymorphisms under investigation, namely the 102T/C and the -1438A/G variations of the 5-HT2A receptor gene, were examined in a case control association study involving 99 stroke patients and a comparable number of controls. Among patients, the prevalence of the homozygous 102T/T genotype was significantly higher than in controls (28.3% vs 13.5%; p < 0.01). The allelic frequency of 102T carriers was also significantly higher in stroke patients than in controls (p = 0.002, OR = 1.88, 95% CI, 1.27-2.80). The association between the 102T allele and stroke was significant in both males and females. There was no association between stroke and the -1438A/G polymorphism. Taken together, this study indicates that the 102T/C polymorphism in the 5-HT2A receptor gene could be an independent risk factor for developing stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17401157     DOI: 10.1385/JMN:30:3:323

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  19 in total

1.  Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone.

Authors:  L Zhang; W Ma; J L Barker; D R Rubinow
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  T102C genetic polymorphism of the 5-HT2A receptor in Chinese hypertensive patients and healthy controls.

Authors:  Bang-ning Yu; An Wang; Gan Zhou; Wei Zhang; Dong-li Hu; Qing Li; Yi-jing He; Hong-Hao Zhou
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-12       Impact factor: 2.557

3.  Genetic liability in stroke: a long-term follow-up study of Danish twins.

Authors:  Søren Bak; David Gaist; Søren Hein Sindrup; Axel Skytthe; Kaare Christensen
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

4.  Platelet activation in unstable coronary disease.

Authors:  D J Fitzgerald; L Roy; F Catella; G A FitzGerald
Journal:  N Engl J Med       Date:  1986-10-16       Impact factor: 91.245

5.  Increased abdominal obesity in subjects with a mutation in the 5-HT(2A) receptor gene promoter.

Authors:  Roland Rosmond; Claude Bouchard; Per Björntorp
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 6.  Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

Authors:  P Vanhoutte; A Amery; W Birkenhäger; A Breckenridge; F Bühler; A Distler; J Dormandy; A Doyle; E Frohlich; L Hansson
Journal:  Hypertension       Date:  1988-02       Impact factor: 10.190

Review 7.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

8.  Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

Authors: 
Journal:  BMJ       Date:  1989-02-18

9.  The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity.

Authors:  Michael J Parsons; Ursula M D'Souza; Maria-Jesus Arranz; Robert W Kerwin; Andrew J Makoff
Journal:  Biol Psychiatry       Date:  2004-09-15       Impact factor: 13.382

10.  A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

Authors:  G Spurlock; A Heils; P Holmans; J Williams; U M D'Souza; A Cardno; K C Murphy; L Jones; P R Buckland; P McGuffin; K P Lesch; M J Owen
Journal:  Mol Psychiatry       Date:  1998-01       Impact factor: 15.992

View more
  2 in total

Review 1.  G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Authors:  Zeinab Vahidinia; Mohammad Taghi Joghataei; Cordian Beyer; Mohammad Karimian; Abolfazl Azami Tameh
Journal:  Mol Neurobiol       Date:  2021-06-12       Impact factor: 5.590

Review 2.  Ischemic Stroke and Sleep: The Linking Genetic Factors.

Authors:  Lyudmila Korostovtseva
Journal:  Cardiol Ther       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.